[Pharmacologic study of 4 fractions of Soja lipexidase].
D000804:Angiotensin II / Q000037:antagonists & inhibitors; D000818:Animals; D004336:Drug Antagonism; D006937:Hypercholesterolemia / Q000139:chemically induced / Q000188:drug therapy; D006949:Hyperlipidemias / Q000139:chemically induced / Q000188:drug therapy; D007035:Hypothermia / Q000139:chemically induced; D000860:Hypoxia / Q000188:drug therapy; D008297:Male; D010105:Oxygenases / Q000032:analysis / Q000494:pharmacology*; D010945:Plants, Edible / Q000201:enzymology; D051381:Rats; D013025:Glycine max; D013501:Surface-Active Agents; D014361:Trypsin Inhibitors / Q000494:pharmacology
D013501:Surface-Active Agents; D014361:Trypsin Inhibitors; D000804:Angiotensin II; D010105:Oxygenases
Etude pharmacologique du quatre fractions de lipoxydase du Soja.